17 Feb SAHPRA has authorised access to molnupiravir
17 February 2022 Embargo: Immediate release Until recently, the treatment options for patients with mild-to-moderate COVID-19 have been limited. New oral antiviral medicines are becoming available for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen and who are at risk of...
